The round was led by Earlybird. Existing investor Speedinvest also participated, along with Defiant, Amino Collective, and Nina Capital.
About Rivia
Rivia is a Zurich-based data engine for clinical trial intelligence that builds a reusable intelligence layer to unify fragmented clinical trial data and enable AI-driven workflows.
Zurich, Switzerland
Read Company ProfileFrequently Asked Questions
What type of funding round did Rivia raise?
Rivia raised a series-a round.
How much did Rivia raise in its series-a?
Rivia raised $15,000,000 USD in its series-a.
Who invested in Rivia's series-a?
The investors in Rivia's series-a are: Earlybird, Speedinvest, Defiant, Amino Collective, Nina Capital.
What type of investment was Rivia's series-a?
Rivia's series-a was a equity investment.
How will Rivia use the funds from its series-a?
Rivia plans to use the funds for: accelerate the next growth phase, scale clinical trial workflows with AI, launch and expand embedded AI agents, support data quality monitoring and control workflows.